BBGBloomberg·5dBusiness
score+0.50
Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion
Original
Boehringer, Sino Enter Cancer Drug Deal Worth Over $7 Billion
“Positive business framing emphasizing a substantial financial commitment to developing experimental cancer treatments.”